As of 2025-07-21, the EV/EBITDA ratio of DNAPrint Genomics Inc (DNAG) is -0.62. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DNAG's latest enterprise value is 5.41 mil USD. DNAG's TTM EBITDA according to its financial statements is -8.68 mil USD. Dividing these 2 quantities gives us the above DNAG EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 4.7x - 7.1x | 5.9x |
| Forward P/E multiples | 4.7x - 7.1x | 5.9x |
| Fair Price | (0.01) - (0.02) | (0.01) |
| Upside | -1198750.3% - -1728149.5% | -1463449.9% |
| Date | EV/EBITDA |
| 2025-06-12 | -0.62 |
| 2025-06-11 | -0.62 |
| 2025-05-22 | -0.63 |
| 2025-05-13 | -0.62 |
| 2025-04-30 | -0.62 |
| 2025-04-23 | -0.62 |